BTCY
Biotricity, Inc.
1W: +5.2%
1M: -21.1%
3M: -39.5%
YTD: -26.3%
1Y: -46.9%
3Y: -92.0%
5Y: -98.4%
$0.22
-0.03 (-10.73%)
After Hours: $0.24 (+0.02, +7.89%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$6.3M
52W Range0.2-0.7536
Volume13,107
Avg Volume69,801
Beta1.40
Dividend—
Analyst Ratings
Company Info
CEOWaqaas Al-Siddiq
Employees55
SectorHealthcare
IndustryMedical - Devices
IPO Date2018-02-16
Websitebiotricity.com
275 Shoreline Drive
Redwood City, CA 94065
US
Redwood City, CA 94065
US
650 832 1626
About Biotricity, Inc.
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
Latest News
Biotricity (NASDAQ:BTCY) Trading Down 1.4% – Time to Sell?
Biotricity (NASDAQ:BTCY) Shares Up 2% – Time to Buy?
Biotricity, Inc. (BTCY) Q3 2026 Earnings Call Transcript
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Rosa David A | A-Award | 75,930 | $1.94 | 2023-03-12 |
| Al-Siddiq Waqaas | A-Award | 1,000,000 | $0.81 | 2023-03-12 |
| Al-Siddiq Waqaas | A-Award | 350,000 | $1.75 | 2023-03-12 |
| Al-Siddiq Waqaas | A-Award | 350,000 | $1.25 | 2023-03-12 |
| Ayanoglou John | A-Award | 218,785 | $0.45 | 2022-12-31 |